288 related articles for article (PubMed ID: 35759017)
1. Survival outcome assessment for triple-negative breast cancer: a nomogram analysis based on integrated clinicopathological, sonographic, and mammographic characteristics.
Sheng DL; Shen XG; Shi ZT; Chang C; Li JW
Eur Radiol; 2022 Oct; 32(10):6575-6587. PubMed ID: 35759017
[TBL] [Abstract][Full Text] [Related]
2. Radiomics features on ultrasound imaging for the prediction of disease-free survival in triple negative breast cancer: a multi-institutional study.
Yu F; Hang J; Deng J; Yang B; Wang J; Ye X; Liu Y
Br J Radiol; 2021 Oct; 94(1126):20210188. PubMed ID: 34478336
[TBL] [Abstract][Full Text] [Related]
3. Nomograms predicting recurrence in patients with triple negative breast cancer based on ultrasound and clinicopathological features.
Zhang L; Zhang X; Han P; Zhao D; Hu N; Fan W; Wang P; Zuo X; Kong H; Peng F; Tian J; Cui H
Br J Radiol; 2022 Sep; 95(1138):20220305. PubMed ID: 35819909
[TBL] [Abstract][Full Text] [Related]
4. A Nomogram to Predict Disease-Free Survival Following Neoadjuvant Chemotherapy for Triple Negative Breast Cancer.
Zhu M; Liang C; Zhang F; Zhu L; Chen D
Front Oncol; 2021; 11():690336. PubMed ID: 34745934
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer.
Yang Y; Wang Y; Deng H; Tan C; Li Q; He Z; Wei W; Zhou E; Liu Q; Liu J
BMC Cancer; 2019 Jun; 19(1):541. PubMed ID: 31170946
[TBL] [Abstract][Full Text] [Related]
6. A Nomogram Based on Radiomics with Mammography Texture Analysis for the Prognostic Prediction in Patients with Triple-Negative Breast Cancer.
Jiang X; Zou X; Sun J; Zheng A; Su C
Contrast Media Mol Imaging; 2020; 2020():5418364. PubMed ID: 32922222
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a prognostic nomogram for patients with triple-negative breast cancer with histology of infiltrating duct carcinoma.
Jing N; Ma MW; Gao XS; Liu JT; Gu XB; Zhang M; Zhao B; Wang Y; Wang XL; Jia HX
Ann Transl Med; 2020 Nov; 8(21):1447. PubMed ID: 33313192
[TBL] [Abstract][Full Text] [Related]
8. Association of sonographic features and molecular subtypes in predicting breast cancer disease outcomes.
Wang H; Yao J; Zhu Y; Zhan W; Chen X; Shen K
Cancer Med; 2020 Sep; 9(17):6173-6185. PubMed ID: 32657039
[TBL] [Abstract][Full Text] [Related]
9. Prediction for pathological and immunohistochemical characteristics of triple-negative invasive breast carcinomas: the performance comparison between quantitative and qualitative sonographic feature analysis.
Li JW; Cao YC; Zhao ZJ; Shi ZT; Duan XQ; Chang C; Chen JG
Eur Radiol; 2022 Mar; 32(3):1590-1600. PubMed ID: 34519862
[TBL] [Abstract][Full Text] [Related]
10. A Web-based Prediction Model for Early Death in Patients With Metastatic Triple-negative Breast Cancer.
Pan WK; Ren SY; Zhu LX; Lin BC
Am J Clin Oncol; 2024 Feb; 47(2):71-80. PubMed ID: 37871164
[TBL] [Abstract][Full Text] [Related]
11. Development of prognostic nomograms using institutional data for patients with triple-negative breast cancer.
Zhou JY; Lu KK; Fu WD; Shi H; Gu JW; Lu YQ; Guo GL
Future Oncol; 2021 Dec; 17(36):5077-5091. PubMed ID: 34704816
[No Abstract] [Full Text] [Related]
12. Development and validation of nomograms integrating immune-related genomic signatures with clinicopathologic features to improve prognosis and predictive value of triple-negative breast cancer: A gene expression-based retrospective study.
Wang K; Li HL; Xiong YF; Shi Y; Li ZY; Li J; Zhang X; Li HY
Cancer Med; 2019 Feb; 8(2):686-700. PubMed ID: 30677255
[TBL] [Abstract][Full Text] [Related]
13. Nomogram for the prediction of triple-negative breast cancer histological heterogeneity based on multiparameter MRI features: A preliminary study including metaplastic carcinoma and non- metaplastic carcinoma.
Kong QC; Tang WJ; Chen SY; Hu WK; Hu Y; Liang YS; Zhang QQ; Cheng ZX; Huang D; Yang J; Guo Y
Front Oncol; 2022; 12():916988. PubMed ID: 36212484
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of Nomograms for Predicting the Prognosis of Triple-Negative Breast Cancer Patients Based on 379 Chinese Patients.
Shi H; Wang XH; Gu JW; Guo GL
Cancer Manag Res; 2019; 11():10827-10839. PubMed ID: 31920392
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
[TBL] [Abstract][Full Text] [Related]
16. Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc.
Cui J; Jiang H
Medicine (Baltimore); 2019 Oct; 98(40):e17370. PubMed ID: 31577739
[TBL] [Abstract][Full Text] [Related]
17. A risk stratification model for predicting brain metastasis and brain screening benefit in patients with metastatic triple-negative breast cancer.
Lin M; Jin Y; Jin J; Wang B; Hu X; Zhang J
Cancer Med; 2020 Nov; 9(22):8540-8551. PubMed ID: 32945619
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a nomogram based on pretreatment dynamic contrast-enhanced MRI for the prediction of pathologic response after neoadjuvant chemotherapy for triple-negative breast cancer.
Li Y; Chen Y; Zhao R; Ji Y; Li J; Zhang Y; Lu H
Eur Radiol; 2022 Mar; 32(3):1676-1687. PubMed ID: 34767068
[TBL] [Abstract][Full Text] [Related]
19. Construction of an immune-related genes nomogram for the preoperative prediction of axillary lymph node metastasis in triple-negative breast cancer.
Tan W; Xie X; Huang Z; Chen L; Tang W; Zhu R; Ye X; Zhang X; Pan L; Gao J; Tang H; Zheng W
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):288-297. PubMed ID: 31858816
[TBL] [Abstract][Full Text] [Related]
20. Sonography with vertical orientation feature predicts worse disease outcome in triple negative breast cancer.
Wang H; Zhan W; Chen W; Li Y; Chen X; Shen K
Breast; 2020 Feb; 49():33-40. PubMed ID: 31677531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
